Heterogeneous nuclear ribonucleoprotein K: Altered pattern of expression associated with diagnosis and prognosis of prostate cancer

British Journal of Cancer

Volumn 100, Issue 10, 2009, Pages 1608-1616

  Barboro, P ^a   Repaci, E ^a   Rubagotti, A ^a,b   Salvi, S ^a   Boccardo, S ^a   Spina, B ^a   Truini, M ^a   Introini, C ^a   Puppo, P ^a   Ferrari, N ^a   Carmignani, G ^b   Boccardo, F ^a,b   Balbi, C ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Biological markers; Heterogeneous nuclear ribonucleoprotein K; Immunohistochemistry; Nuclear matrix; Prostate cancer; Western blot

Indexed keywords

BICALUTAMIDE; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER DIAGNOSIS; CELL NUCLEUS MATRIX; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION;

AGED; CARCINOMA; CELL LINE, TUMOR; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN K; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PHOSPHORYLATION; PROGNOSIS; PROSTATIC NEOPLASMS; PROTEIN KINASES; PROTEOMICS; TISSUE DISTRIBUTION; TUMOR MARKERS, BIOLOGICAL;

EID: 67349229799     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605057     Document Type: Article

References (39)

1. Alberti I, Barboro P, Barbesino M, Sanna P, Pisciotta L, Parodi S, Nicolö G, Boccardo F, Galli S, Patrone E, Balbi C (2000) Changes in the expression of cytokeratins and nuclear matrix proteins are correlated with the level of differentiation in human prostate cancer. J Cell Biochem 79: 471-485
2. Alberti I, Parodi S, Barboro P, Sanna P, Nicolö G, Allera C, Patrone E, Galli S, Balbi C (1996) Differential nuclear matrix-intermediate filament expression in human prostate cancer in respect to benign prostatic hyperplasia. Cancer Lett 109: 193 - 198
3. Armitage P, Berry G, Matthews JNS. (2000) Statistical Methods in Medical Research (ed 4). Blackwell Publishing: Oxford, United Kingdom
4. Barboro P, Alberti I, Sanna P, Parodi S, Balbi C, Allera C, Patrone E (1996) Changes in the cytoskeletal and nuclear matrix proteins in rat hepatocyte neoplastic nodules in their relation to the process of transformation. Exp Cell Res 225: 315-327
5. Barboro P, D'Arrigo C, Repaci E, Bagnasco L, Orecchia P, Carnemolla B, Patrone E, Balbi C (2009) Proteomic analysis of the nuclear matrix in the early stages of rat liver carcinogenesis: Identification of differentially expressed and MAR-binding proteins. Exp Cell Res 315: 226-239
6. Barboro P, Rubagotti A, Boccardo F, Carnemolla B, D'Arrigo C, Patrone E, Balbi C (2005) Nuclear matrix protein expression in prostate cancer: possible prognostic and diagnostic applications. Anticancer Res 25: 3999-4004
7. Barboro P, Rubagotti A, Orecchia P, Spina B, Truini M, Repaci E, Carmignani G, Romagnoli A, Introini C, Boccardo F, Carnemolla B, Balbi C (2008) Differential proteomic analysis of nuclear matrix in muscle-invasive bladder cancer: potential to improve diagnosis and prognosis. Cell Oncol 30: 13-26
8. Benelli R, Monteghirfo S, Balbi C, Barboro P, Ferrari N (2009) Novel antivascular efficacy of metronomic docetaxel therapy in prostate cancer: hnRNP K as a player. Int J Cancer, in press DOI: 10.1002/ijc.24305
9. Boccardo F, Medicina D, Galmozzi F, Emionite L, Lo Casto M (2005) 4-OH tamoxifen does not interfere with bicalutamide inhibitory effects on human prostatic cancer cells in vitro. Anticancer Res 25: 4277-4280
10. Boccardo F, Rubagotti A, Carmignani G, Romagnoli A, Nicolö G, Barboro P, Parodi S, Patrone E, Balbi C (2003) Nuclear matrix proteins changes in cancerous prostate tissues and their prognostic value in clinically localized prostate cancer. Prostate 55: 259 - 264
11. Bomsztyk K, Denisenko O, Ostrowski J (2004) hnRNP K: one protein multiple processes. BioEssays 26: 629-638
12. Bomsztyk K, Van Seuningen I, Suzuki H, Denisenko O, Ostrowski J (1997) Diverse molecular interactions of the hnRNP K protein. FEBS Lett 403: 113-115
13. Candiano G, Bruschi M, Musante L, Santucci L, Ghiggeri GM, Carnemolla B, Orecchia P, Zardi L, Righetti PG (2004) Blue silver: a very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis 25: 1327-1333
14. Carpenter B, MacKay C, Alnabulsi A, MacKay M, Telfer C, Melvin WT, Murray GI (2006a) The roles of heterogeneous nuclear ribonucleopro-teins in tumour development and progression. Biochim Biophys Acta 1765:85-100
15. Carpenter B, McKay M, Dundas SR, Lawrie LC, Telfer C, Murray GI (2006b) Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancer. Br J Cancer 95: 921-927
16. Carpenter B, Murray GI (2007) Replay: Evidence for heterogeneous nuclear ribonucleoprotein K over expression in oral squamous cell carcinoma. Br J Cancer 97: 576
17. Chen LC, Hsueh C, Tsang NM, Liang Y, Chang KP, Hao SP, Yu JS, Chang YS (2008) Heterogeneous ribonucleoprotein K and thymidine Phosphorylase are independent prognostic and therapeutic markers for nasopharyngeal carcinoma. Clin Cancer Res 14: 3807-3813
18. Damber JE, Aus G (2008) Prostate cancer. Lancet 317: 1710-1721
19. Dundr M, Misteli T (2001) Functional architecture in the cell nucleus. Biochem J 356: 297-310
20. Fleiss JL (1981) Statistical Methods for rates and proportions, 2nd edn John Wiley & Sons, Inc: New York
21. Habelhah H, Shah K, Huang L, Ostareck-Lederer A, Burlingame AL, Shokat KM, Hentze MW, Ronai Z (2001) ERK phosphorylation drives cytoplasmic accumulation of hnRNP-K and inhibition of mRNA translation. Nat Cell Biol 3: 325 - 330
22. Hatakeyama H, Kondo T, Fujii K, Nakanishi Y, Kato H, Fukuda S, Hirohashi S (2006) Protein clusters associated with carcinogenesis, histological differentiation and nodal metastasis in esophageal cancer. Proteomics 6: 6300-6316
23. Heukeshoven J, Dernick R (1988) Improved silver staining procedure for fast staining in PhastSystem development unit. I. Staining of sodium dodecyl sulfate gels. Electrophoresis 9: 28-32
24. Inoue A, Sawata SY, Taira K, Wadhwa R (2007) Loss-of-function screening by randomized intracellular antibodies: identification of hnRNP-K as a potential target for metastasis. Proc Natl Acad Sci USA 104: 8983-8988
25. Kim D, Tucker PW (2006) A regulated nucleocytoplasmic shuttle contributes to Bright's function as a transcriptional activator of immunoglobulin genes. Mol Cell Biol 26: 2187-2201
26. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680 - 685
27. Leman ES, Getzenberg RH (2008) Nuclear structure as a source of cancer specific biomarkers. J Cell Biochem 104: 1988 - 1993
28. Lynch M, Chen L, Ravitz MJ, Mehtani S, Korenblat K, Pazin MJ, Schmidt EV (2005) HnRNP K binds a core polypyrimidine element in the eukaryotic translation initiation factor 4E (eIF4E) promoter, and its regulation of eIF4E contributes to neoplastic transformation. Mol Cell Biol 25: 6436-6453
29. Mandal M, Vadlamudi R, Nguyen D, Wang RA, Costa L, Bagheri-Yarmand R, Mendelsohn J, Kumar R (2001) Growth factors regulate heterogeneous nuclear ribonucleoprotein K expression and function. J Biol Chem 276: 9699-9704
30. Michelotti GA, Michelotti EF, Pullner A, Duncan RC, Eick D, Levens D (1996) Multiple single-stranded cis elements are associated with activated chromatin of the human c-myc gene in vivo. Mol Cell Biol 16: 2656-2669
31. Nagano K, Masters JR, Akpan A, Yang A, Corless S, Wood C, Hastie C, Zvelebil M, Cramer R, Naaby-Hansen S (2004) Differential protein synthesis and expression levels in normal and neoplastic human prostate cells and their regulation by type I and II interferons. Oncogene 23: 1693-1703
32. Ostrowski J, Bomsztyk K (2003) Nuclear shift of hnRNP K protein in neoplasms and other states of enhanced cell proliferation. Br J Cancer 89: 1493 - 1501
33. Ostrowski J, Kawata Y, Schullery DS, Denisenko ON, Bomsztyk K (2003) Transient recruitment of the hnRNP K protein to inducibly transcribed gene loci. Nucleic Acids Res 31: 3954-3962
34. Ostrowski J, Schullery DS, Denisenko ON, Higaki Y, Watts J, Aebersold R, Stempka L, Gschwendt M, Bomsztyk K (2000) Role of tyrosine phosphorylation in the regulation of the interaction of heterogenous nuclear ribonucleoprotein K protein with its protein and RNA partners. J Biol Chem 275: 3619-3628
35. Pino I, Pío R, Toledo G, Zabalegui N, Vicent S, Rey N, Lozano MD, Torre W, García-Foncillas J, Montuenga LM (2003) Altered patterns of expression of members of the heterogeneous nuclear ribonucleoprotein (hnRNP) family in lung cancer. Lung Cancer 41: 131-143
36. Roychoudhury P, Chaudhuri K (2007) Evidence for heterogeneous nuclear ribonucleoprotein K overexpression in oral squamous cell carcinoma. Br J Cancer 97: 574-575
37. Shi L, Ko S, Kim S, Echchgadda I, Oh T, Song CS, Chatterjee B (2008) Loss of androgen receptor in aging and oxidative stress through Myb protooncoprotein-regulated reciprocal chromatin dynamics of p53 and poly(ADP-ribose) polymerase PARP-1. J Biol Chem 283: 36474-36485
38. Wang LG, Johnson EM, Kinoshita Y, Babb JS, Buckley MT, Liebes LF, Melamed J, Liu XM, Kurek R, Ossowski L, Ferrari AC (2008) Androgen receptor overexpression in prostate cancer linked to Pura loss from a novel repressor complex. Cancer Res 68: 2678 - 2688
39. Zink D, Fischer AH, Nickerson JA (2004) Nuclear structure in cancer cells. Nat Rev Cancer 4: 677-687